Amniotic Membrane Market Worth US$ 2,577.74 Mn by 2027 COVID-19 Impact and Global Analysis by The Insight Partners

According to our new market research study titled ”Amniotic Membrane Market –Global Analysis and Forecast – by Enzyme, Application, and End User” the global amniotic membrane market is expected to reach US$ 2,577.74 million by 2027 from US$ 1,484.83 million in 2019; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report highlights the trends prevalent in the global amniotic membrane market, and the drivers and deterrents pertaining to its growth.

Amniotic membrane is a combination of tissues and cells that help in healing the wound by acting as a foundation for re growth of the soft tissues. These are mostly used in eye surgery as a biological bandage to heal or replace damaged eye tissue. The growing applications of amniotic membrane and rising number of target patient population are the key factors for the market growth. However, challenges in using amniotic membranes are likely to restrain the market growth during the forecast period. Additionally, the outbreak of COVID–19 pandemic has negatively impacted the market growth. However, the increase in clinical trials for medical treatment through amniotic membrane/fluid in North America and Europe is likely to retract the market growth.

Get sample Research Pages of Amniotic Membrane Market study at:

Amniotic Membrane Market Competitive Landscape and Key Development

Applied Biologics LLC; Integra Life Sciences Corporation; Skye Biologics Inc.; MiMedx; Organogenesis Inc.; Smith & Nephew; Amniox Medical, Inc.; Katena Products. Inc.; Amnio Technology, LLC; and Surgenex, LLC are among the prominent players operating in the amniotic membrane market. The market players are focused on organic strategies to sustain their position in the market. For instance, in August 2020, TissueTech, Inc.’s proprietary PROKERA Slim corneal bandage, an amniotic membrane medical device was approved for eye care professionals’ use in Taiwan.

Growing Applications of Amniotic Membrane

Amniotic membrane has been widely used in various surgical subspecialties and ophthalmology procedures. It is also used in the reconstruction of the conjunctiva surface, limbal stem cell deficiency or persistent epithelial defects, corneal ulcer, and ocular surface burns. Moreover, amniotic membrane is used for treating infectious and sterile corneal ulcers. There is significant tissue loss in case of corneal ulcers; the amniotic membrane can be used in layers to build thickness of cornea, thereby avoiding cornea transplantation. Amniotic membrane transplant can be performed quickly in case of ocular surface burn, and it has been reported to accelerate healing and reduce fibrosis, neovascularization, and patient's pain.

Further, the amniotic membrane has wound healing properties, along with a number of cytokines, growth factors, and antibacterial properties that reduce pain and enhance healing process. It is non-immunogenic, reduces inflammation and scar tissue formation, and provides a matrix for the proliferation of cells and migration.

Amniotic membrane is a source of stem cells, mimics human oral mucosa, and provides anti-inflammatory, immunomodulatory, and anti-scarring effects, which makes it a treatment option for periodontal regeneration. Due to such characteristics of amniotic membrane, its allografts have been used in soft orthopedic tissues and spine applications to prevent scar tissue formation, reduce pain, and promote healing.

Amniotic Membrane Market: Segmental Overview

Based on enzyme, the amniotic membrane market is segmented into cryopreserved amniotic membrane and dehydrated amniotic membrane. The cryopreserved amniotic membrane segment held a larger share of the market in 2019; whereas, the dehydrated amniotic membrane segment is anticipated to register a higher CAGR in the market during the forecast period. The growth of the cryopreserved amniotic membrane segment is attributed to its wide usage as a graft or dressing in surgical procedures. It can be stored for a longer period and extensive product offerings are provided by companies in the market. On the other hand, the dehydrated amniotic membrane is expected to be the fastest-growing segment. The application of dehydrated amniotic membrane is increasing due to its stable shelf life, and presence of active biological components that are required for medical uses. Additionally, a dehydrated amniotic membrane is used to treat a no healing defect on the ocular surface, such as a neurotrophic corneal ulcer.

Based on application, the amniotic membrane market is segmented into surgical wounds, ophthalmology, and others. The surgical wounds segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. The growth of this segment is determined due to advantages of the amniotic membrane. The amniotic membrane contains number of essential growth factors and cytokines, which enhances the wound healing process and reduces the pain. The membrane also has anti scarring properties and thus reduces scar tissue formation.

Buy Complete Report of Amniotic Membrane Market Study at:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876


Back to news